Cargando…

The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases

BACKGROUND: One of the more common behavioral manifestations of dementia-related disorders is severe problems with out-of-home mobility. Various efforts have been attempted to attain a better understanding of mobility behavior, but most studies are based on institutionalized patients and the assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoval, Noam, Auslander, Gail K, Freytag, Tim, Landau, Ruth, Oswald, Frank, Seidl, Ulrich, Wahl, Hans-Werner, Werner, Shirli, Heinik, Jeremia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291469/
https://www.ncbi.nlm.nih.gov/pubmed/18366748
http://dx.doi.org/10.1186/1471-2318-8-7
_version_ 1782152456963096576
author Shoval, Noam
Auslander, Gail K
Freytag, Tim
Landau, Ruth
Oswald, Frank
Seidl, Ulrich
Wahl, Hans-Werner
Werner, Shirli
Heinik, Jeremia
author_facet Shoval, Noam
Auslander, Gail K
Freytag, Tim
Landau, Ruth
Oswald, Frank
Seidl, Ulrich
Wahl, Hans-Werner
Werner, Shirli
Heinik, Jeremia
author_sort Shoval, Noam
collection PubMed
description BACKGROUND: One of the more common behavioral manifestations of dementia-related disorders is severe problems with out-of-home mobility. Various efforts have been attempted to attain a better understanding of mobility behavior, but most studies are based on institutionalized patients and the assessment usually relies on reports of caregivers and institutional staff, using observational approaches, activity monitoring, or behavioral checklists. The current manuscript describes the research protocol of a project that measures mobility in Alzheimer's disease and related cognitive disorders in an innovative way, by taking advantage of advanced tracking technologies. METHODS/DESIGN: Participants are 360 demented persons, mildly cognitively impaired persons, and unimpaired controls aged ≥ 65 in Israel and Germany. Data regarding space-time activities will be collected via a GPS tracking kit for a period of 4 weeks in 3 waves (one year apart) with the same participants (using a repeated measures design). Participants will be interviewed by use of a battery of instruments prior to and following GPS data collection. Further, a family member will complete a questionnaire both before and after data tracking. Statistical analyses will strive to explain differences in mobility based on a wide range of socio-structural, clinical, affect-related and environmental variables. We will also assess the impact of the use of advanced tracking technology on the quality of life of dementia patients and care givers, as well as its potential as a diagnostic tool. Systematic assessment of ethical issues involved in the use of tracking technology will be an integral component of the project. DISCUSSION: This project will be able to make a substantial contribution to basic as well as applied and clinical aspects in the area of mobility and cognitive impairment research. The innovative technologies applied in this study will allow for assessing a range of dimensions of out-of-home mobility, and provide better quality data.
format Text
id pubmed-2291469
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22914692008-04-10 The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases Shoval, Noam Auslander, Gail K Freytag, Tim Landau, Ruth Oswald, Frank Seidl, Ulrich Wahl, Hans-Werner Werner, Shirli Heinik, Jeremia BMC Geriatr Study Protocol BACKGROUND: One of the more common behavioral manifestations of dementia-related disorders is severe problems with out-of-home mobility. Various efforts have been attempted to attain a better understanding of mobility behavior, but most studies are based on institutionalized patients and the assessment usually relies on reports of caregivers and institutional staff, using observational approaches, activity monitoring, or behavioral checklists. The current manuscript describes the research protocol of a project that measures mobility in Alzheimer's disease and related cognitive disorders in an innovative way, by taking advantage of advanced tracking technologies. METHODS/DESIGN: Participants are 360 demented persons, mildly cognitively impaired persons, and unimpaired controls aged ≥ 65 in Israel and Germany. Data regarding space-time activities will be collected via a GPS tracking kit for a period of 4 weeks in 3 waves (one year apart) with the same participants (using a repeated measures design). Participants will be interviewed by use of a battery of instruments prior to and following GPS data collection. Further, a family member will complete a questionnaire both before and after data tracking. Statistical analyses will strive to explain differences in mobility based on a wide range of socio-structural, clinical, affect-related and environmental variables. We will also assess the impact of the use of advanced tracking technology on the quality of life of dementia patients and care givers, as well as its potential as a diagnostic tool. Systematic assessment of ethical issues involved in the use of tracking technology will be an integral component of the project. DISCUSSION: This project will be able to make a substantial contribution to basic as well as applied and clinical aspects in the area of mobility and cognitive impairment research. The innovative technologies applied in this study will allow for assessing a range of dimensions of out-of-home mobility, and provide better quality data. BioMed Central 2008-03-26 /pmc/articles/PMC2291469/ /pubmed/18366748 http://dx.doi.org/10.1186/1471-2318-8-7 Text en Copyright © 2008 Shoval et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Shoval, Noam
Auslander, Gail K
Freytag, Tim
Landau, Ruth
Oswald, Frank
Seidl, Ulrich
Wahl, Hans-Werner
Werner, Shirli
Heinik, Jeremia
The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title_full The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title_fullStr The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title_full_unstemmed The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title_short The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases
title_sort use of advanced tracking technologies for the analysis of mobility in alzheimer's disease and related cognitive diseases
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291469/
https://www.ncbi.nlm.nih.gov/pubmed/18366748
http://dx.doi.org/10.1186/1471-2318-8-7
work_keys_str_mv AT shovalnoam theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT auslandergailk theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT freytagtim theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT landauruth theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT oswaldfrank theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT seidlulrich theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT wahlhanswerner theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT wernershirli theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT heinikjeremia theuseofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT shovalnoam useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT auslandergailk useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT freytagtim useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT landauruth useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT oswaldfrank useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT seidlulrich useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT wahlhanswerner useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT wernershirli useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases
AT heinikjeremia useofadvancedtrackingtechnologiesfortheanalysisofmobilityinalzheimersdiseaseandrelatedcognitivediseases